An Improved 211At-Labeled Agent for PSMA-Targeted α-Therapy.
Mease RC, Kang CM, Kumar V, Banerjee SR, Minn I, Brummet M, Gabrielson KL, Feng Y, Park A, Kiess AP, Sgouros G, Vaidyanathan G, Zalutsky MR, Pomper MG.
Mease RC, et al. Among authors: kumar v.
J Nucl Med. 2022 Feb;63(2):259-267. doi: 10.2967/jnumed.121.262098. Epub 2021 Jun 4.
J Nucl Med. 2022.
PMID: 34088772
Free PMC article.